Multifocal motor neuropathy?

summary

Multifocal motor neuron disease (MND) is a group of chronic progressive neurodegenerative diseases with unknown etiology and selective invasion of spinal cord anterior horn cells, brainstem motor neurons, cortical pyramidal cells and pyramidal tract. The incidence rate is about 1 to 3/10 million per year, and the prevalence rate is 4 to 8/10 million per year. Because most patients die within 3~5 years after the onset of symptoms, the prevalence of this disease is close to the incidence rate. The etiology is still unclear. It is generally believed that with the increase of age, it is caused by the exposure of genetically susceptible individuals to adverse environment, that is, genetic factors and environmental factors jointly lead to the occurrence of motor neuron disease.

Multifocal motor neuropathy?

It may be family genetic factors, such as progressive hypertrophic polyneuropathy, hereditary sensory neuropathy. Multiple neuropathy of unknown origin, recurrent multiple neuropathy, chronic progressive multiple neuropathy, etc. No matter what the cause is, axonal degeneration often occurs.

Combined with a variety of physical instruments, the drug can accurately reach the lesion site, dredge the human meridians, improve the local blood circulation, enhance the immune function, promote the metabolism of local tissue, promote the generation of new squamous epithelial cells, so as to achieve the local muscle repair function.

Multifocal motor neuropathy is a kind of erosive nerve damage disease, and the disease is different in the early, middle and late stages. Only in the early and middle stages of treatment can we have the best recovery. The main treatment is invigorating spleen and kidney, eliminating wind, resolving phlegm and removing blood stasis. Through the reconstruction of the dynamic balance of the patient's body, to achieve the recovery of the body structure and function, so as to achieve the therapeutic effect.

matters needing attention

The incidence rate of multifocal motor neuropathy is about 1 to 3/10 per year, with a prevalence rate of 4 to 8/10 per year. Because most patients die within 3~5 years after the onset of symptoms, the prevalence of this disease is close to the incidence rate. Therefore, we must pay more attention.